Compare NTES & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTES | ELV |
|---|---|---|
| Founded | 1997 | 1944 |
| Country | China | United States |
| Employees | 25382 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.7B | 85.7B |
| IPO Year | N/A | 2001 |
| Metric | NTES | ELV |
|---|---|---|
| Price | $118.72 | $418.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 19 |
| Target Price | $160.00 | ★ $383.56 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-28-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.61% | 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.00 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | $9.57 | N/A |
| Revenue Next Year | $8.57 | $3.07 |
| P/E Ratio | $79.88 | ★ $51.94 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $106.06 | $273.71 |
| 52 Week High | $159.55 | $416.56 |
| Indicator | NTES | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 50.15 | 69.91 |
| Support Level | $107.83 | $307.16 |
| Resistance Level | $120.05 | N/A |
| Average True Range (ATR) | 3.10 | 9.86 |
| MACD | -0.12 | -0.11 |
| Stochastic Oscillator | 63.48 | 90.08 |
Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.